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Background: The clinical significance of incomplete coronary revascularization (ICR) following ACS is unknown. We explored the prevalence and 
impact of ICR in the ACUITY trial.
Methods: Quantitative coronary angiography (QCA) of the entire coronary tree was performed in 2,954 patients with ACS who underwent PCI in the 
ACUITY trial. Patients with prior CABG or for whom a staged procedure was planned were excluded. In a sensitivity analysis, ICR was deemed present 
if any lesion with a final diameter stenosis (DS) ranging from ≥30% to ≥70% by QCA in any vessel with a reference diameter ≥2.0 mm was left 
untreated. The primary outcome was the 1-year composite rate of major adverse cardiac events (MACE: death/MI/unplanned revascularization).
Results: Using QCA DS cutoffs of ≥70%, ≥60%, ≥50%, ≥40% and ≥30%, the prevalence of ICR was 17%, 25%, 37%, 55%, and 75% respectively. 
MACE at 1 year was increased with all definitions of ICR (Table). Using a DS ≥50%, ICR was associated with a higher 1-year rate of MI (12.0% vs. 
8.2%, HR[95%CI] = 1.50 [1.18,1.89], p = 0.0007) and unplanned revascularization (15.7% vs. 10.2%, HR[95%CI] = 1.58 [1.28,1.96], p <0.0001), 
with a trend toward increased mortality (3.1% vs. 2.2%, HR[95%CI] = 1.43 [0.90,2.27], p = 0.13). The impact of ICR on MACE was similar whether or 
not a chronic total occlusion was present.
Conclusions: Depending on the threshold %DS, ICR is present in 17%-75% of patients with ACS after PCI. Regardless of the definition, ICR after PCI 
was significantly associated with 1-year MACE. 
DS Threshold Level for ICR MACE% (n)(ICR) MACE% (n)(CR) HR [95% CI] p
≥30% 20.4% (433) 15.3% (112) 1.36 [1.11,1.68] 0.003
≥40% 21.6% (338) 16.1% (207) 1.38 [1.16,1.64] 0.0002
≥50% 23.4% (248) 16.6% (297) 1.47 [1.24,1.74] <0.0001
≥60% 25.2% (178) 17.1% (367) 1.55 [1.30,1.85] <0.0001
≥70% 26.4% (127) 17.6% (418) 1.59 [1.30,1.93] <0.0001
